Supreme Pharmaceuticals (CNSX:SL)

Supreme Pharmaceuticals (CNSX:SL)

Share Price
0 (0 %)
Market Cap
$0.00 m
Proactive Investors - Run By Investors For Investors

Supreme Pharmaceuticals

Supreme Pharmaceuticals Inc. is a Company that is dedicated to providing and developing an in-licensed technology with an IP portfolio aimed at targeting Obesity. The platform will address the fundamental changes in healthcare and enabling relief for millions people in Obesity. In addition, the company is also pursuing opportunities in the Medical Marijuana Industry.

Market: CSE:SL
Sector: Pharmaceuticals
col 3
col 4
col 5
col 6

Supreme Pharmaceuticals Timeline

Supreme Pharmaceuticals said on Tuesday it has closed the third and largest tranche of a non-brokered private placement for proceeds of C$10,610,625, and aggregate proceeds from three tranches of C$14,949,755
Supreme Pharmaceuticals says it has strengthened its board of directors, following receipt of the federal licence to cultivate marijuana at its seven-acre (342,000 square feet) hybrid greenhouse facility in Kincardine, Ontario

Supreme Pharma quarterly loss narrows

The Canadian development company says it intends to generate revenue, once licensed, from the sale of dried marijuana and similar products.
Supreme extended the expiry date of warrants issued in connection to its private placement closing on September 22, 2015 and October 6, 2015. The 4.478 million warrants issued on September 22, 2014, due to expire on September 22, 2015 will now expire September 22, 2016 while 897,000 warrants issued on October 6, 2014...
Copyright ©, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use